The added value of immediate breast reconstruction to health-related quality of life of breast cancer patients

Autor: Sabine Siesling, K.M. de Ligt, T. van Dalen, M.T.F.D. Vrancken Peeters, A.C.M. van Bommel, John H. Maduro, Marc A.M. Mureau, K. Schreuder
Přispěvatelé: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Health Technology & Services Research, TechMed Centre, Plastic and Reconstructive Surgery and Hand Surgery
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Time Factors
SATISFACTION
SURGERY
medicine.medical_treatment
Mammaplasty
Tissue Expansion
Personal Satisfaction
Surgical Flaps
0302 clinical medicine
Breast cancer
Quality of life
Surveys and Questionnaires
REPORTED OUTCOMES
030212 general & internal medicine
Breast Implantation
Information provision
Netherlands
Immediate breast reconstruction
Carcinoma
Ductal
Breast
Tissue Expansion Devices
General Medicine
Middle Aged
BREAST-Q
Psychosocial Functioning
Mental Health
Oncology
Patient Satisfaction
030220 oncology & carcinogenesis
Female
Sexual Health
Breast reconstruction
Psychosocial
Mastectomy
medicine.medical_specialty
Hospitals
Low-Volume
Breast Neoplasms
Patient-centred care
Hospitals
General
03 medical and health sciences
SDG 3 - Good Health and Well-being
Internal medicine
MASTECTOMY
medicine
Humans
Hospitals
Teaching
Aged
Health related quality of life
business.industry
Significant difference
medicine.disease
Carcinoma
Intraductal
Noninfiltrating
Case-Control Studies
Superficial Back Muscles
business
Hospitals
High-Volume
Zdroj: European Journal of Surgical Oncology, 46(10), 1848-1853. ELSEVIER SCI LTD
European journal of surgical oncology, 46(10), 1848-1853. Elsevier
European Journal of Surgical Oncology, 46(10), 1848-1853. W.B. Saunders
ISSN: 0748-7983
DOI: 10.1016/j.ejso.2020.06.009
Popis: Background: Postmastectomy immediate breast reconstruction (IBR) may improve the quality of life (QoL) of breast cancer patients. Guidelines recommend to discuss the option IBR with all patients undergoing mastectomy. However, substantial hospital variation in IBR-rates was previously observed in the Netherlands, influenced by patient, tumour and hospital factors and clinicians’ believes. Information provision about IBR may have a positive effect on receiving IBR and therefore QoL. This study investigated patient-reported QoL of patients treated with mastectomy with and without IBR. Methods: An online survey, encompassing the validated BREAST-Q questionnaire, was distributed to a representative sample of 1218 breast cancer patients treated with mastectomy. BREAST-Q scores were compared between patients who had undergone mastectomy either with or without IBR. Results: A total of 445 patients were included for analyses: 281 patients with and 164 without IBR. Patients who had received IBR showed significantly higher BREAST-Q scores on “psychosocial well-being” (75 versus 67, p < 0.001), “sexual well-being” (62 versus 52, p < 0.001) and “physical well-being” (77 versus 74, p = 0.021) compared to patients without IBR. No statistically significant difference was found for “satisfaction with breasts” (64 versus 62, p = 0.21). Similar results were found after multivariate regression analyses, revealing IBR to be an independent factor for a better patient-reported QoL. Conclusions: Patients diagnosed with breast cancer with IBR following mastectomy report a better QoL on important psychosocial, sexual and physical well-being domains. This further supports the recommendation to discuss the option of IBR with all patients with an indication for mastectomy and to enable shared decision-making.
Databáze: OpenAIRE
Externí odkaz: